A negative correlation between CD31+ endothelium-derived EVs, markers of endothelial cell apoptosis, and DLCO values has been demonstrated in stable COPD patients, thus suggesting that CD31+ EVs could represent a marker of lung parenchyma destruction and emphysema [38]. Here, PECAM1 is linked to chronic obstructive pulmonary disease.